CYP2C19 variants and epoxyeicosatrienoic acids in patients with microvascular angina

BACKGROUND: Categorization as a cytochrome P450 (CYP) 2C19 poor metabolizer (PM) is reported to be an independent risk factor for cardiovascular disease. Epoxyeicosatrienoic acids (EETs) are metabolites of arachidonic acid by CYP2C19 epoxygenases and anti-inflammatory properties, especially in micro...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Int J Cardiol Heart Vasc
Autors principals: Akasaka, Tomonori, Sueta, Daisuke, Arima, Yuichiro, Tabata, Noriaki, Takashio, Seiji, Izumiya, Yasuhiro, Yamamoto, Eiichiro, Tsujita, Kenichi, Kojima, Sunao, Kaikita, Koichi, Kajiwara, Ayami, Morita, Kazunori, Oniki, Kentaro, Saruwatari, Junji, Nakagawa, Kazuko, Hokimoto, Seiji
Format: Artigo
Idioma:Inglês
Publicat: Elsevier 2017
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5458130/
https://ncbi.nlm.nih.gov/pubmed/28616567
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijcha.2017.03.001
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars